Good news for children and young people, bad news for Johnson & Johnson.
A sign shows the way to a recovery area to monitor any immediate side effects from the COVID-19 vaccine on Dec. 17, 2020, in Reno, Nevada.
Patrick T. Fallon /AFP via Getty Images
Many people never experience the least bit of discomfort from the COVID-19 vaccines, but mild side effects are common. They include swelling in the affected arm, nausea and chills.
Make that second appointment and get your final dose for full protection.
MediaNews Group/Reading Eagle via Getty Images
An immunologist explains that you get some protection from the first dose of the mRNA vaccines but you need two to build up strong immunity, particularly to newer coronavirus variants.
A COVID-19 vaccine is administered at a clinic at Olympic Stadium in Montréal on March 1, 2021, marking the beginning of mass vaccination in the Province of Québec based on age.
THE CANADIAN PRESS/Paul Chiasson
With four COVID-19 vaccines approved for use in Canada, it’s time to answer FAQs about efficacy, immunity, eradication and variants.
Nurse Nicole Chang celebrates after receiving one of the first injections of the COVID-19 vaccine Dec. 16 at Ronald Reagan UCLA Medical Center in Westwood, California.
Brian van der Brug/Getty Images
Millions of vaccinated people have been waiting for guidelines on what they can do safely. The CDC says it’s OK to gather with other vaccinated people, but it’s still best to avoid travel.
Nurse Natalie O'Connor loads syringes with the Moderna COVID-19 vaccine in February 2021.
Joseph Prezioso/AFP via Getty Images
Researchers are closely watching the coronavirus mutants to make sure vaccines can be adjusted if necessary. But scientists don’t know whether vaccines will be effective in those already vaccinated.
Vaccinated people are wondering whether they can ease social distancing and mask-wearing.
AP Photo/Darko Bandic
You’ve been vaccinated; can you now safely see your friends and family? New research hints that vaccinated people may be less likely to transmit the coronavirus, but they are not 100% in the clear.
Believe it or not, this little guy has inspired new scientific thought about the COVID-19 vaccine.
Peter Dazeley via Getty Images
Vaccine hesitancy will not go away fast. In fact, there are parallels in the physical world to how quickly or slowly an object returns to its normal state.
Joe Biden, then president-elect, received his COVID-19 vaccination in December.
Joshua Roberts via Getty Images
Rollout of COVID-19 vaccines has begun. But getting the jab doesn’t mean abandoning masks, distancing and handwashing. Here’s why the current preventive measures must continue post-vaccine.
If too many Americans refuse to take the COVID-19 vaccine, achieving population immunity will be difficult.
Paul Hennessy/NurPhoto via Getty Images
The shipment of goods to suppliers has become technologically sophisticated. Delays in getting out the COVID-19 vaccine to people show that the breakdowns come down to something more basic.
The French government will not accept any passengers arriving from the U.K. amid fears over the new mutant coronavirus strain.
Steve Parsons/PA Images via Getty Images
A new strain of the SARS-CoV-2 virus that causes COVID-19 appears to be spreading fast in the UK. This probably isn’t a big problem, but the data isn’t in yet.
A dose of the Pfizer vaccine being prepared to be given to a health worker in California, USA.
EPA-EFE
Experts from across The Conversation assess the work that’s helped us reach vaccine roll-out, how this could play out, and the risk of vaccine hesitancy.
The number one scientific breakthrough for 2020: multiple vaccines to prevent COVID-19.
Philippe Raimbault/Photodisc via Getty Images
The development of multiple vaccines against the virus that causes COVID-19 has been hailed as the breakthrough of 2020. But there were many more supporting discoveries that made this possible.
Sandra Lindsay, a nurse at Long Island Jewish Medical Center, is given the COVID-19 vaccine – she is one of the first in the US to receive it.
EPA/Mark Lennihan
Here’s what we still need to find out before we can know when we’ll be able to return to our pre-coronavirus ways.
The pharmaceutical industry opposes the suspension of intellectual property rights on COVID-19 vaccines and treatments, and no pharma companies have yet contributed to the COVID-19 Technology Access Pool.
(Shutterstock)
We should applaud drug companies for developing COVID-19 vaccines in record time, but let’s not be under any illusion about the profits that are motivating them.
A nurse prepares a shot for a clinical trial of a COVID-19 vaccine candidate developed by the National Institutes of Health and Moderna Inc., on July 27, 2020 in Binghamton, N.Y.
(AP Photo/Hans Pennink, File)
With COVID-19 vaccine announcements making headlines, non-scientists need to know what clinical trial results mean. Here are some key points to look for in vaccine trial reports.
Now there is a third possible vaccine for fighting the COVID-19 pandemic.
Jakub Porzycki/NurPhoto via Getty Images
There is now a third vaccine that prevents COVID-19 infections. It isn’t quite as effective as the other two vaccines but it has advantages that may make it the frontrunner.